{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:36:50Z","timestamp":1786541810417,"version":"build-2736575974"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Mr. Willem BakhuysRoozeboom Foundation","award":["2022-7"],"award-info":[{"award-number":["2022-7"]}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["RIA2020I-3305"],"award-info":[{"award-number":["RIA2020I-3305"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2026,8,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Global tuberculosis (TB) incidence is slowly decreasing, partly because undiagnosed TB continues to fuel transmission. Point-of-care TB triage tests (TTTs) performed near a patient or at the site of patient care may help bridge this gap, but head-to-head comparisons of different host blood biomarkers within the same cohort are limited. In ambulatory adults in Uganda aged \u226515 years with any cough, fever, weight loss, or night sweats, we evaluated the diagnostic accuracy of C-reactive protein (CRP), monocyte-to-lymphocyte ratio (MLR), interferon-gamma-induced protein 10 (IP-10), and hemoglobin (anemia) head-to-head using a reference standard comprised of culture and\/or Xpert MTB\/RIF Ultra. Cut-offs of CRP and anemia were from World Health Organization (WHO) recommendations, MLR from the literature, and IP-10 from Youden\u2019s index. We included 623 participants (193 people living with HIV [PLWHIV]), of whom 111 (18%) were reference standard-positive. Sensitivity and specificity (95% CI) were 91% (84%\u201396%) and 78% (74%\u201381%) for CRP (\u226510 mg\/L); 72% (63%\u201378%) and 80% (77%\u201384%) for MLR (\u22650.378); 86% (79%\u201392%) and 73% (69%\u201377%) for IP-10 (\u226528.75); 69% (60%\u201378%) and 76% (72%\u201380%) for anemia (&lt;12 g\/dL [female], &lt;13 g\/dL [male]), respectively. At 90% sensitivity, specificity was 76% (58%\u201383%) for CRP; 62% (47%\u201374%) for MLR; 64% (47%\u201375%) for IP-10, and 28% (17%\u201351%) for anemia. There was no significant difference for any of the four TTTs in diagnostic odds ratio between participants with and without a history of previous TB, between smokers and non-smokers, and between males and females. However, MLR performed significantly (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001) worse in PLWHIV. Combining two index tests in parallel testing improved sensitivity up to 96% at the expense of reduced specificity. The applicable WHO minimum target product profile of 90% sensitivity and 60% specificity was met for CRP irrespective of HIV status, and for IP-10 and MLR when cut-offs were adjusted. Sex, prior history of smoking, and TB did not impact diagnostic performance. Parallel testing may be suitable in high TB prevalence settings, where minimizing missed cases and ensuring timely referral for confirmatory testing are priorities.\n                    <\/jats:p>\n                    <jats:sec>\n                      <jats:title>IMPORTANCE<\/jats:title>\n                      <jats:p>This study provides strong evidence that host blood protein biomarkers (C-reactive protein [CRP], interferon gamma-induced protein 10 [IP-10], and monocyte-to-lymphocyte ratio [MLR]) can serve as effective point-of-care tools for tuberculosis (TB) triage. CRP reliably meets the World Health Organization (WHO) high-sensitivity target product profile criteria across people living with HIV and HIV-negative populations, while optimized cut-offs enable IP-10 and MLR to achieve comparable performance, expanding feasible options where CRP is unavailable or unaffordable. The minimal influence of sex, smoking history, or prior TB supports broad, unstratified implementation. Evidence that parallel testing reduces missed TB cases is particularly relevant in high-burden settings. Clinically, these findings support integrating biomarker-based triage into routine screening to improve early case detection, although it may require further external validation to ensure cut-offs used are robust and not overly data-driven. For policymakers, the results justify incorporating biomarker-based point-of-care tests into national TB screening algorithms to accelerate diagnosis, improve referral efficiency, and reduce TB transmission.<\/jats:p>\n                    <\/jats:sec>\n                  <\/jats:sec>","DOI":"10.1128\/jcm.00046-26","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:10:25Z","timestamp":1785161425000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Head-to-head evaluation of host blood biomarkers for point-of-care TB triage: diagnostic accuracy study"],"prefix":"10.1128","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2141-8696","authenticated-orcid":false,"given":"Kevin","family":"Komakech","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03dmz0111","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]},{"id":[{"id":"https:\/\/ror.org\/05grdyy37","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centres","place":["Amsterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Sserwadda","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05grdyy37","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centres","place":["Amsterdam, Netherlands"]},{"id":[{"id":"https:\/\/ror.org\/03dmz0111","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sserubiri","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03dmz0111","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Joloba","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03dmz0111","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]},{"name":"National Tuberculosis Reference Laboratory\/WHO Supranational Reference Laboratory","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9216-2415","authenticated-orcid":false,"given":"Grant","family":"Theron","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05bk57929","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Science and Technology-National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University","place":["Cape Town, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cobelens","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05grdyy37","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centres","place":["Amsterdam, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1643-110X","authenticated-orcid":true,"given":"Willy","family":"Ssengooba","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03dmz0111","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University","place":["Kampala, Uganda"]},{"id":[{"id":"https:\/\/ror.org\/03dmz0111","id-type":"ROR","asserted-by":"publisher"}],"name":"Makerere University Lung Institute","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_5_2_2","unstructured":"WHO. 2024. WHO: global tuberculosis report. World Health Organization. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/7292c91e-ffb0-4cef-ac39-0200f06961ea\/content."},{"key":"e_1_3_5_3_2","unstructured":"WHO. 2015. WHO: the END TB strategy. World Health Organization. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/d128ca35-55c7-4ec8-b2f3-987ca112a4a2\/content."},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix354"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.03.021"},{"key":"e_1_3_5_6_2","unstructured":"WHO. 2021. WHO consolidated guidelines on tuberculosis. Module 2: screening-systematic screening for tuberculosis disease. World Health Organization"},{"key":"e_1_3_5_7_2","unstructured":"WHO. 2025. WHO: target product profiles for tuberculosis screening tests. Geneva. World Health Organization. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/848c63db-fa29-459b-aaaf-1b758370711f\/content."},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.4081\/monaldi.2023.2528"},{"key":"e_1_3_5_9_2","unstructured":"ISO15189:2022. 2022. Medical laboratories \u2014 Requirements for quality and competence. https:\/\/www.iso.org\/standard\/76677.html."},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12022"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103257"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0380-2"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.17.0078"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000003901"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47923-w"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27746"},{"key":"e_1_3_5_17_2","volume-title":"Statistical methods in diagnostic medicine","author":"Zhou X-H","year":"2014","unstructured":"Zhou X-H, Obuchowski NA, McClish DK. 2014. Statistical methods in diagnostic medicine. John Wiley & Sons."},{"key":"e_1_3_5_18_2","volume-title":"Guideline on haemoglobin cutoffs to define anaemia in individuals and populations","author":"WHO","year":"2024","unstructured":"WHO. 2024. Guideline on haemoglobin cutoffs to define anaemia in individuals and populations. World Health Organization. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK602198\/."},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac548"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001893"},{"key":"e_1_3_5_21_2","unstructured":"WHO. 2024. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis\u2013rapid diagnostics for tuberculosis detection. World Health Organization. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/b9125fa4-dcc0-418a-9421-56c28275461d\/content."},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","unstructured":"Olesen SV Nielsen LK Gredal L. 2026. Evaluation of the analytical performance of hemoglobin analysis on the point-of-care testing device HemoCue Hb 801. medRxiv. doi:10.1101\/2025.08.26.25334339","DOI":"10.1101\/2025.08.26.25334339"},{"key":"e_1_3_5_23_2","first-page":"93","article-title":"Diagnostic accuracy of interferon gamma-induced protein 10 for tuberculosis: a meta-analysis","volume":"7","author":"Guo SJ","year":"2014","unstructured":"Guo SJ, Jia LQ, Hu QJ, Long HY, Pang CS, Wen FQ. 2014. Diagnostic accuracy of interferon gamma-induced protein 10 for tuberculosis: a meta-analysis. Int J Clin Exp Med 7:93\u2013100.","journal-title":"Int J Clin Exp Med"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4466-5"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26176"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05916-z"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202308-752OC"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piac015"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000091"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.12.019"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/35073648"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-012-0118-8"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15222860"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08342-5"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.00046-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.00046-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:00:49Z","timestamp":1786539649000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jcm.00046-26"}},"subtitle":[],"editor":[{"given":"Mark","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,12]]}},"alternative-id":["10.1128\/jcm.00046-26"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00046-26","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"2026-01-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00046-26"}}